Telerehabilitation Physical Activity for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to help individuals with mild memory problems, known as amnestic mild cognitive impairment, become more active. The study tests a 12-week program delivered through mobile technology to increase daily steps, aiming to slow the progression toward Alzheimer's Disease. Participants pair with a caregiver and divide into two groups: one receives the new activity program, called the Telerehabilitation Physical Activity Behavioral (TPAB) intervention, and the other follows their usual routine. This study suits those diagnosed with amnestic mild cognitive impairment who are currently not very active and have a caregiver willing to join the trial. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you have been on stable doses of medication for at least the previous 30 days before starting the study.
What prior data suggests that this telerehabilitation physical activity intervention is safe for individuals with mild cognitive impairment?
Research has shown that telerehabilitation physical activity programs are generally safe for people with mild memory and thinking problems. Early results suggest these programs are easy to manage and have few side effects.
Studies have found that exercise programs using technology can benefit older adults, even those with mild cognitive issues. Participants usually report positive experiences and do not encounter serious problems.
Although few studies have examined the exact program in this trial, similar programs have not raised major safety concerns. This type of program primarily focuses on increasing daily steps, a safe and common exercise goal. Overall, evidence suggests that the telerehabilitation approach is safe, but participants should consult their healthcare providers.12345Why are researchers excited about this trial?
Researchers are excited about the Telerehabilitation Physical Activity Behavioral (TPAB) intervention for mild cognitive impairment because it takes a novel approach by integrating technology with behavior-change techniques. Unlike traditional treatments that may focus on medication or in-person therapy, TPAB leverages telerehabilitation to deliver weekly sessions remotely, making it accessible and convenient for patients and their caregivers. This method emphasizes patient-centered communication and uses established theories like Social Cognitive Theory and Operant Conditioning to encourage increased daily physical activity, such as taking more steps. The hope is that this innovative approach will not only improve physical activity levels but also potentially enhance cognitive function and quality of life for individuals with mild cognitive impairment.
What evidence suggests that the Telerehabilitation physical activity behavioral intervention is effective for improving physical activity in individuals with mild cognitive impairment?
Research has shown that telerehabilitation programs, which use mobile technology to encourage exercise, can increase physical activity in older adults, including those without memory problems. One study found that these programs significantly boost daily step counts. This trial will evaluate the Telerehabilitation Physical Activity Behavioral (TPAB) intervention, which participants may receive, to determine its effectiveness in slowing the progression from mild memory issues to Alzheimer's Disease. Studies have also shown that regular exercise can improve overall health and quality of life, even for those with memory challenges. Although specific data on telerehabilitation's impact on memory is limited, this method appears promising for increasing physical activity and potentially reducing dementia risk.12456
Are You a Good Fit for This Trial?
This trial is for pairs of individuals where one person has mild cognitive impairment (MCI) aged between 50-85, and their caregiver who is over 19. The patient should have a diagnosis of amnestic MCI, score within a specific range on a cognitive assessment test, not be very physically active, and be stable on medications. Both must speak English and have internet access.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week mobile-health technology physical activity behavior change intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Telerehabilitation physical activity behavioral (TPAB) intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Creighton University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator